[1]李小侠.血清谷氨酸脱氢酶与其他肝功能指标联合检测在肝病诊断中的临床意义[J].陕西医学杂志,2020,49(12):1677-1680.[doi:DOI:10.3969/j.issn.1000-7377.2020.12.037]
　LI Xiaoxia..Clinical significance of combined detection of serum glutamate dehydrogenase and other liver function indexes in the diagnosis of liver disease[J].,2020,49(12):1677-1680.[doi:DOI:10.3969/j.issn.1000-7377.2020.12.037]
点击复制

血清谷氨酸脱氢酶与其他肝功能指标联合检测在肝病诊断中的临床意义
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
49
期数:
2020年12期
页码:
1677-1680
栏目:
临床检验
出版日期:
2020-12-05

文章信息/Info

Title:
Clinical significance of combined detection of serum glutamate dehydrogenase and other liver function indexes in the diagnosis of liver disease
作者:
李小侠
陕西省人民医院检验科(西安 710068)
Author(s):
LI Xiaoxia.
Department of Clinical Laboratory,Shaanxi Provincial People's Hospital(Xi'an 710068)
关键词:
谷氨酸脱氢酶;  肝功能指标;  联合检测;  肝病
Keywords:
Glutamate dehydrogenase;  Liver function index;  Combined detection;  Liver disease
分类号:
R575
DOI:
DOI:10.3969/j.issn.1000-7377.2020.12.037
文献标志码:
A
摘要:
目的:探讨肝细胞损伤时谷氨酸脱氢酶(GLDH)变化特点及其与总胆汁酸(TBA)、丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)、谷氨酰转肽酶(GGT)和胆碱酯酶(CHE)等指标联合检测在肝病诊断中的临床意义。方法:选取肝病患者240例(肝病组)作为研究对象,其中急性病毒性肝炎69例(急性肝炎组),慢性活动性肝炎52例(慢活肝组),慢性迁延性肝炎49例(慢迁肝组),肝硬化43例(肝硬化组),原发性肝癌27例(肝癌组)。选取同期健康体检者100例作为对照组。检测血清中GLDH、TBA、ALT、AST、GGT和CHE水平并进行比较。结果:不同肝病组血清GLDH、TBA、ALT、AST、GGT水平均高于对照组,CHE水平均低于对照组(均P<0.05)。GLDH异常率从高到低依次为急性肝炎组、肝硬化组、慢活肝组、肝癌组和慢迁肝组。ALT和AST异常率由高到低依次为急性肝炎组、慢活肝组、肝癌组、慢迁肝组和肝硬化组。TBA异常率由高到低依次为急性肝炎组、慢活肝组、肝硬化组、肝癌组和慢迁肝组。GGT异常率由高到低依次为肝癌组、急性肝炎组、肝硬化组、慢活肝组和慢迁肝组。CHE异常率由低到高依次为肝硬化组、慢活肝组、肝癌组、急性肝炎组和慢迁肝组。结论:GLDH可作为肝细胞损伤的特异性指标,与血清TBA、ALT、AST、GGT和CHE等肝功能指标联合检测对肝细胞损伤程度的综合评估及对肝病的鉴别诊断具有重要意义。
Abstract:
Objective:To investigate the changes of GLDH in hepatocyte injury and the clinical significance of combined detection of GLDH,TBA,ALT,AST,GGT and CHE in the diagnosis of liver diseases.Methods:240 patients with liver disease(liver disease group)were selected as the research objects,including 69 cases of acute viral hepatitis(acute hepatitis group),52 cases of chronic active hepatitis(chronic active liver group),49 cases of chronic persistent hepatitis(chronic progressive liver group),43 cases of liver cirrhosis(cirrhosis group)and 27 cases of primary liver cancer(liver cancer group).100 healthy people were selected as the control group.The serum levels of GLDH,TBA,ALT,AST,GGT and CHE were detected and compared.Results:The serum levels of GLDH,TBA,ALT,AST and GGT in different liver disease groups were higher than those in the control group,and the CHE level was lower than that in the control group(all P<0.05).The abnormal rate of GLDH from high to low was acute hepatitis group,cirrhosis group,chronic active liver group,liver cancer group and chronic progressive liver group.The abnormal rates of ALT and AST from high to low were acute hepatitis group,chronic active liver group,liver cancer group,chronic progressive liver group and cirrhosis group.The abnormal rate of TBA from high to low was acute hepatitis group,chronic active liver group,cirrhosis group,liver cancer group and chronic progressive liver group.The abnormal rate of GGT from high to low was liver cancer group,acute hepatitis group,cirrhosis group,chronic active liver group and chronic progressive liver group.The abnormal rate of CHE from low to high were cirrhosis group,chronic active liver group,liver cancer group,acute hepatitis group and chronic liver disease group.Conclusion:GLDH can be used as a specific indicator of hepatocyte injury.Combined detection of GLDH with serum TBA,ALT,AST,GGT and CHE is of great significance for comprehensive evaluation of hepatocyte injury and differential diagnosis of liver disease.

参考文献/References:

[1] 赵元明.血清谷氨酸脱氢酶活性检测在肝胆疾病中的临床价值[J].检验医学,2013,28(2):163-165.
[2] 邢 俊,李江华.血清谷氨酸脱氢酶检测在肝细胞损伤性疾病中的临床应用价值[J].黑龙江医药科学,2007,30(5):34-35.
[3] 肖晓光,孙国华,王 华,等.血清谷氨酸脱氢酶的检测及对肝病诊断的临床应用[J].大连医科大学学报,2004,26(1):48-50.
[4] 雷 鸣,朱志斌.血清GLD和(ALT+AST)/GLD比值对肝病诊断的临床探讨[J].实用医技杂志,2007,14(28):3842-3844.
[5] 李松鹏,徐丽萍,景红艳.血清总胆汁酸测定在肝病诊断中的应用价值分析[J].中外医疗,2019,38(19):189-192.
[6] 孙 航.肝病患者血清总胆汁酸的变化及其临床意义[J].吉林医学,2013,34(3):420-421.
[7] 易光明.肝病患者115例血清总胆汁酸的变化及其临床意义[J].长江大学学报:自然科学版,2010,7(4):65-66.
[8] 李三景.血清胆碱酯酶活动度对慢性重型肝炎早期治疗的临床分析[J].中国误诊学杂志,2011,11(13):3087.
[9] 王 波,刘祥红,张冬青.肝病患者血清总胆汁酸与酶学检测及其临床意义[J].宁夏医学院学报,2001,23(1):43-44.
[10] 门莎莎,董振南,贾兴旺,等.AFP、TBA、GGT和ALT联合检测对原发性肝癌的诊断价值[J].标记免疫分析与临床,2011,18(2):68-70.
[11] Di FR,Wilquet V,Ciardiello MA,et al.NADP+-dependent glutamate dehydrogenase in the antarctic psychrotolerant bacterium psychrobacter sp.TAD1.charaterization,protein and DNA sequence,and relationship to other glutamate dehydrogenases[J].Eur J Bioche,2000,267(1):121-131.
[12] 肖晓光,孙国华,王 华.血清谷氨酸脱氢酶的检测及对肝病诊断的临床应用[J].大连医科大学学报,2004,26(1):48-50.
[13] 胡江红,袁平宗,李 勇.血清谷氨酸脱氢酶与胆碱酯酶诊断肝脏疾病价值分析[J].实用医院临床杂志,2019,16(3):115-117.
[14] 郑慧慧.肝病患者血清谷氨酸脱氢酶的检测及其预后变化规律[J].医学信息,2016,29(27):81-82.
[15] 潘 峰,李荣斌,张丽霞.血清GLDH和AST-m 在诊断几种肝脏疾病中的意义[J].中国实验诊断学,2005,9(6):986-987.
[16] 胡汉宁,贺小玲,李小明,等.血清谷氨酸脱氢酶检测的临床应用[J].武汉大学学报:医学版,2001,22(1):58-60.
[17] 邢 俊,李江华.血清谷氨酸脱氢酶检测在肝细胞损伤性疾病中的临床应用价值[J].黑龙江医药科学,2007,30(5):34-35.
[18] 郑 奇,杨 丽,曾 霖,等.慢性乙型肝炎患者血清谷氨酸脱氢酶活性、ApoAⅠ、ApoB100含量的动态变化及临床意义[J].实用医院临床杂志,2019,16(6):124-126.
[19] 赵元明.血清谷氨酸脱氢酶活性检测在肝胆疾病中的临床价值[J].检验医学,2013,28(2):163-165.
[20] 钟 琼,袁汉尧,钟毓琼.肝病患者血清谷氨酸脱氢酶和总胆汁酸的检测及其临床意义[J].广东医学院学报,2003,21(6):569-570.

相似文献/References:

[1]朱芳丽,马厉英,马晓莹,等.急性胰腺炎患者血清CXC趋化因子配体10和CC类趋化因子22水平与疾病严重程度关系及临床诊断价值研究[J].陕西医学杂志,2024,(6):788.[doi:DOI:10.3969/j.issn.1000-7377.2024.06.014]
　ZHU Fangli,MA Liying,MA Xiaoying,et al.Relationship between serum CXCL10,CCL22 levels and disease severity in patients with acute pancreatitis and their clinical diagnostic value[J].,2024,(12):788.[doi:DOI:10.3969/j.issn.1000-7377.2024.06.014]

更新日期/Last Update: 2020-12-11